Dentsply Sirona, Inc. (NASDAQ: XRAY)
Hagens Berman Sobol Shapiro LLP reminds investors in Dentsply Sirona Inc. (NASDAQ: XRAY) to the firm's investigation into possible disclosure violations.
If you exchanged your shares of Sirona Dental Systems, Inc. (NASDAQ: SIRO) for shares of DENTSPLY International Inc. or purchased or otherwise acquired Dentsply Sirona (NASDAQ: XRAY) securities between February 29, 2016 and August 7, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing XRAY@hbsslaw.com.
On February 29, 2016 DENTSPLY International Inc. and Sirona Dental Systems, Inc. completed their merger to form Dentsply Sirona Inc.
On August 7, 2018, Dentsply Sirona announced its second quarter 2018 financial results. In addition to news that it recorded a goodwill and intangible impairment charge of $1.265 billion, management slashed adjusted EPS guidance for 2018 to the range of $2.00 to $2.15 per share, down from its previous estimate of $2.55 to $2.65 per share.
This news drove the price of Dentsply Sirona shares down as much as $9.03, or about 18.5%, to close at $39.41 on August 7, 2018.
“We’re focused on investors’ losses and management’s historical statements about the Company’s Technologies and Equipment segment and certain distributor relationships,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.